Meet the CEO
Since becoming CEO of Chelonia, Silvano Coletti (photo) has led a strategic and cultural transformation to build a leading innovation-driven company globally powered by access to the most brilliant minds and outstanding scientists. He introduced the most powerful cross-linked platform between innovation-driven companies and academia. Mathematica and computation is the theory revolutionizing projects' technology and science led by Chelonia. Backed by training as engineer and executive education at Harvard Business School, Silvano is a former student of Prof.Ilya Prigogine (Nobel laureate 1977) at Institute Solvay (Belgium) and fellow at EPFL (Switzerland). He seats on boards of scientific committees and corporate advisory boards. Silvano’s passion for innovation and social entrepreneurship is evident: in addition to his career at Chelonia, he worked with the largest NGOs in Africa where he served as delegate at the United Nations.
Nobel Prize serves scientific board of
Chelonia Applied Science
In 2013, Arieh Warshel, Distinguished Professor of Chemistry and Biology at the University of Southern California’s Dornsife College of Letters, Arts and Sciences, was awarded a Nobel Prize for Chemistry for his groundbreaking research in theoretical chemistry. Dr. Warshel holds the Dana and David Dornsife Chair in Chemistry at USC, where he has served on the faculty since 1976.
A member of the National Academy of Sciences, and a Foreign Member of the Russian Academy of Sciences, Dr. Warshel has pioneered computer simulations of the functions of biological molecules. He has authored over 500 peer-reviewed articles, including the book, Computer Modeling of Chemical Reactions in Enzymes and Solutions (Wiley Professional, 1991). He co-developed computer programs for molecular simulations which have been used extensively in different applications including the development of new pharmaceuticals.
James Beacham (photo) is the Chelonia Ambassador-at-Large and member of Scientific Committee of Chelonia. He does experimental high energy particle physics working on an experiment at the LHC, ATLAS. His research focuses on finding explanations for some of the key unsolved mysteries of the universe, like determining what dark matter is, whether the Higgs boson is standard or not-so-standard, why gravity is so weak compared to the other forces of nature, and whether there are hidden, dark sector forces that we've yet to uncover in collider experiments. BBC television nominated James as one of the two best science communicators in history.
Social Media Strategy for Science and Research
Gabriella Bernardi (photo) is the Chelonia Social Media Manager.
Journalist and writer specialized in the popularization of science, she graduated in physics from the University of Turin, and holds a Master in Journalism and Science Communication.
Awarded with Voltolino Prize for scientific journalism by the Italian Union of Scientific Journalists (UGIS), since 2008 she is member of the European Union of Science Journalists’ Association (EUSJA). She is a scientific writer for several newspapers and magazines and author of six astronomy books.
Andrea Beccari, PhD at the next
AI in Healthcare Symposium
Andrea Beccari (scientist and head of Exscalate platform) 28 of November will talk at the next event organized by Life Science Alliance and MOLIT Institute for Personalized Medicine. This virtual symposium brings together researchers from across the globe to address the promises and challenges of artificial intelligence in healthcare. Over two days it will highlight the latest insights and applications of AI across the whole healthcare system, from bench to bedside our global community. Our talk will be on smart in silico poly pharmacological drug design platform selecting molecules active against the ZIKA virus.
Frontrunners with Exscalate4COV
Thierry Breton, European Commissioner for the Internal Market, said: “The Exscalate4Cov platform brings innovation to drug discovery in Europe and worldwide. It demonstrates the value of true pan-European cooperation by joining the best capacities Europe has to offer in the fields of biomedical science and high-performance computing. We will continue to mobilise all technologies available, including artificial intelligence, to fight the coronavirus.”
Exscalate4CoV is the public-private consortium supported by the European Commission’s Horizon 2020 to counter the Coronavirus pandemic and improve the management and care of patients. At the core of Exscalate4CoV is Exscalate (EXaSCale smArt pLatform Against paThogEns), at present the most powerful and cost-efficient intelligent supercomputing platform in the world. Exscalate has a "chemical library" of 500 billion molecules and a processing capacity of more than 3 million molecules per second. The consortium, coordinated by Dompé Farmaceutici , is composed by 18 institutions from seven European countries. Chelonia is leading the project work package "Communication, Dissemination & Exploitation". CEO's Chelonia has been appointed Project Innovation Manager for the whole consortium.
Eran Segal and
Coronavirus Census Collective
Silvano Coletti co-authors with Eran Segal (photo) from Weizmann Institute of Science and others outstanding scientists from MIT, Broad Institute, Harvard and ETH the call-to-action "Coronavirus Census Collective" to track the spread of the novel coronavirus. The global collaboration is an open-access platform whereby voluntarily reported data can be used to predict the location of future COVID-19 outbreaks.
Meet Members of Chelonia
James Beacham, member of Scientific Committee of Chelonia, is the experimental high-energy particle physicist working with the ATLAS collaboration at CERN's Large Hadron Collider. As part of the ATLAS collaboration at CERN's Large Hadron Collider, one of the teams that discovered the Higgs boson in 2012, James Beacham is on the hunt for evidence of new particles -- dark photons, gravitons, dark matter and exotic Higgs bosons among them.
Piero Carninci, member of Scientific Committee of Chelonia, currently is Team Leader for Laboratory for Transcriptome Technology and Deputy Centre Director at the RIKEN Centre for Integrative Medical Sciences in Yokohama (Japan) and advisor at Human Technopole in Milano (Italy). Piero is responsible for the creation and development of various new technologies for DNA and RNA sequencing and analysis. He has also been involved in leading many large scale national and international initiatives, such as FANTOM, ENCODE and more recently the Human Cell Atlas.
Where You Can Meet Chelonia Soon